Bayer secures end of Roundup litigation in Australia
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out
more.
We are serious about journalism.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
NZ sharemaket up 0.1% despite 'volatile' markets
The S&P/NZX 50 Index closed at 12,338.57, up 18.38 points or 0.15%.
NZX-listed companies take stock in wake of US tariff moves
Wine makers, manufacturers and others mull what trade wars will bring.
Analysts struggle to find upside from Trump tariffs
‘They've forgotten the lessons of the Great Depression,’ one analyst said.
Commercial property trends: AI, sustainability and growing confidence
Falling rates and green tech shape property investment’s future.
